Maxnerva Technology Services Limited (Maxnerva Tech) filed its Monthly Return for the period ended 31 March 2026, confirming that there were no changes to either its authorised or issued share structures during the month.

Authorised share capital remained at 1.00 billion ordinary shares with a par value of HKD 0.10 each, translating to HKD 100.00 million.

Issued share capital held steady at 706.17 million ordinary shares, and the company continued to hold no treasury shares. As a result, the total issued share count remained 706.17 million.

Public-float compliance was affirmed, exceeding the Main Board’s 25% minimum threshold.

Share-based incentives also showed no dilution effect in March. All outstanding share options—totalling 6.92 million across three grant dates (31 Aug 2017, 12 Nov 2018, and 9 Apr 2022)—remained unexercised, raising no funds and issuing no new shares during the month.

No warrants, convertibles, or other equity-linked instruments were outstanding or exercised, and the company reported no other share movements.

Overall, Maxnerva Tech’s capital structure remained unchanged in March 2026, reflecting a stable equity base as the firm entered the new quarter.